enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: CORRESP
Filing Date: 26 Feb 2026Report Date:
Accepted: 26 Feb 2026 09:20 a.m.
Accession Number: 0001193125-26-074564
File Number: None
Film Number: None